FEDERATED HERMES, INC. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 57 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 59.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,085
-2.0%
88
-2.2%
0.00%
Q2 2023$1,107
+0.1%
900.0%0.00%
Q1 2023$1,106
+7.3%
900.0%0.00%
Q4 2022$1,031
+3.1%
90
-1.1%
0.00%
Q3 2022$1,0000.0%910.0%0.00%
Q2 2022$1,0000.0%910.0%0.00%
Q1 2022$1,0000.0%910.0%0.00%
Q4 2021$1,0000.0%91
-58.6%
0.00%
Q3 2021$1,0000.0%2200.0%0.00%
Q2 2021$1,0000.0%220
-0.9%
0.00%
Q1 2021$1,000
-50.0%
2220.0%0.00%
Q4 2020$2,000
+100.0%
222
-33.3%
0.00%
Q3 2020$1,0000.0%333
-15.1%
0.00%
Q2 2020$1,000
-50.0%
392
-61.8%
0.00%
Q1 2020$2,000
-66.7%
1,027
-43.9%
0.00%
Q4 2019$6,000
-25.0%
1,8320.0%0.00%
Q3 2019$8,000
-50.0%
1,832
-31.1%
0.00%
Q2 2019$16,000
-72.9%
2,657
-68.8%
0.00%
Q1 2019$59,000
-68.4%
8,513
-82.4%
0.00%
-100.0%
Q4 2018$187,000
-28.1%
48,323
-0.8%
0.00%0.0%
Q3 2018$260,000
-40.9%
48,707
-45.6%
0.00%0.0%
Q2 2018$440,000
-49.9%
89,540
-18.0%
0.00%
-66.7%
Q1 2018$879,000
-27.2%
109,179
-7.2%
0.00%0.0%
Q4 2017$1,207,000117,7100.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Newtyn Management, LLC 362,335$3,714,0000.57%
Rubric Capital Management LP 410,244$4,205,0000.52%
WITTENBERG INVESTMENT MANAGEMENT, INC. 83,811$859,0000.37%
Yakira Capital Management, Inc. 83,969$861,0000.28%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$153,0000.10%
STONEBRIDGE CAPITAL MANAGEMENT INC 18,550$200,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 66,498$681,0000.05%
Cannell & Co. 75,467$774,0000.03%
Trexquant Investment LP 21,347$219,0000.02%
PDT Partners, LLC 58,004$595,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders